{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:26:34Z","timestamp":1794590794755,"version":"4.9.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Nodal marginal zone lymphoma (NMZL) is a rare indolent B-cell lymphoma without a disease-defining phenotype. The distinction from other small B-cell lymphomas is challenging, especially from t(14;18)-negative follicular lymphoma (FL). To find out whether molecular analysis could help in separating NMZL from other small B-cell lymphomas, we analyzed a cohort of 52 patients with the diagnosis or differential diagnosis of NMZL using targeted next-generation sequencing and gene expression profiling (GEP). After morphological and mutational analysis, 38 (73%) patients were classified as NMZL, 8 (15%) patients as t(14;18)-negative FL, and 6 (12%) patients as chronic lymphocytic leukemia\/small lymphocytic lymphoma with atypical phenotype. The most frequently mutated gene in NMZL was KLF2 (34%), followed by KMT2D (21%) and TBL1XR1 (16%). Overall, the NF-\u03baB pathway (13%), the NOTCH pathway (16%), and genes involved in chromatin remodeling and transcriptional regulation (55%) were frequently affected. Confirming the classification based on pathological and genetic features, GEP revealed distinct transcriptional profiles for NMZL and t(14;18)-negative FL. Although the latter group showed upregulation of genes associated with the germinal center and the interleukin-4 pathway, NMZL revealed upregulation of genes identified in memory B cells. In summary, despite showing genetic heterogeneity, NMZL is characterized by recurrent genetic alterations resulting in perturbations of specific pathways. These alterations, although not specific per se, render very characteristic genetic profiles, and when used in the context of other findings, are a useful adjunct to distinguish NMZL from other small B-cell lymphomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020849","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:54:03Z","timestamp":1789073643000},"page":"7673-7687","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas"],"prefix":"10.1182","volume":"10","author":[{"given":"Vanessa","family":"Borgmann","sequence":"first","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Gierer","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7565-0554","authenticated-orcid":false,"given":"Stefanie","family":"Paigin","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6010-3348","authenticated-orcid":false,"given":"Antonio","family":"Vogelsberg","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7888-6810","authenticated-orcid":false,"given":"Jan","family":"Bosch-Schips","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"2Department of Pathology, Hospital Universitari de Bellvitge, Institut d\u2019Investigacions Biomediques de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mankel","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sotlar","sequence":"additional","affiliation":[{"name":"3Institute of Pathology, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0948-1392","authenticated-orcid":false,"given":"Matthias S.","family":"Dettmer","sequence":"additional","affiliation":[{"name":"4Institute of Pathology, Klinikum Stuttgart, Stuttgart, Germany"},{"name":"5Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bonzheim","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-293X","authenticated-orcid":false,"given":"Falko","family":"Fend","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5365","authenticated-orcid":false,"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-793X","authenticated-orcid":false,"given":"Dominik","family":"Nann","sequence":"additional","affiliation":[{"name":"1Institute of Pathology and Neuropathology, Eberhard Karls University of T\u00fcbingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2026111311221022800_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2026111311221022800_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"2026111311221022800_bib3","first-page":"421","volume-title":"The International Consensus Classification of Myeloid and Lymphoid Neoplasms","author":"Dogan","year":"2025"},{"key":"2026111311221022800_bib4","first-page":"412","volume-title":"Haematolymphoid Tumours, Part B","author":"Natkunam","year":"2024","edition":"5th ed"},{"issue":"1","key":"2026111311221022800_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3324\/haematol.2021.278755","article-title":"Marginal zone lymphoma: present status and future perspectives","volume":"107","author":"Cheah","year":"2022","journal-title":"Haematologica"},{"issue":"7","key":"2026111311221022800_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review","volume":"98","author":"van den Brand","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"2026111311221022800_bib7","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.bneo.2024.100031","article-title":"CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas","volume":"1","author":"Ghione","year":"2024","journal-title":"Blood Neoplasia"},{"issue":"5","key":"2026111311221022800_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1309\/AJCPEMVXES72DUIF","article-title":"Clinicopathologic features of CD5-positive nodal marginal zone lymphoma","volume":"140","author":"Jaso","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"2026111311221022800_bib9","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2026111311221022800_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2559.2007.02951.x","article-title":"Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases","volume":"52","author":"Naresh","year":"2008","journal-title":"Histopathology"},{"issue":"18","key":"2026111311221022800_bib11","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","article-title":"The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas","volume":"7","author":"Salaverria","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"2026111311221022800_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"issue":"5","key":"2026111311221022800_bib13","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"issue":"10","key":"2026111311221022800_bib14","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/leu.2009.108","article-title":"Identification of MNDA as a new marker for nodal marginal zone lymphoma","volume":"23","author":"Kanellis","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"2026111311221022800_bib15","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/cancers12061669","article-title":"Discovery of novel recurrent mutations and clinically meaningful subgroups in nodal marginal zone lymphoma","volume":"12","author":"Koh","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2026111311221022800_bib16","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"2026111311221022800_bib17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2026111311221022800_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13015","article-title":"Recurrent mutations in genes involved in nuclear factor-\u03baB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications","volume":"70","author":"van den Brand","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"2026111311221022800_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2026111311221022800_bib20","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2026111311221022800_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40425-015-0088-7","article-title":"nCounter((R)) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)","volume":"3","author":"Cesano","year":"2015","journal-title":"J Immunother Cancer"},{"key":"2026111311221022800_bib22","doi-asserted-by":"crossref","first-page":"RP92511","DOI":"10.7554\/eLife.92511","article-title":"mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming","volume":"12","author":"Bischof","year":"2024","journal-title":"Elife"},{"issue":"1","key":"2026111311221022800_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1134\/S0006297920010058","article-title":"Transcription factor KLF2 and its role in the regulation of inflammatory processes","volume":"85","author":"Turpaev","year":"2020","journal-title":"Biochemistry (Mosc)"},{"issue":"29","key":"2026111311221022800_bib24","doi-asserted-by":"crossref","first-page":"18504","DOI":"10.1074\/jbc.272.29.18504","article-title":"Two potent nuclear localization signals in the gut-enriched Kruppel-like factor define a subfamily of closely related Kruppel proteins","volume":"272","author":"Shields","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"2026111311221022800_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"2026111311221022800_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000478-199901000-00006","article-title":"Primary nodal marginal zone lymphomas of splenic and MALT type","volume":"23","author":"Campo","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2026111311221022800_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/leu.2017.270","article-title":"Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing","volume":"32","author":"Zamo","year":"2018","journal-title":"Leukemia"},{"issue":"7574","key":"2026111311221022800_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"2","key":"2026111311221022800_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1073\/pnas.1013168108","article-title":"Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression","volume":"108","author":"Hart","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2026111311221022800_bib30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"17","key":"2026111311221022800_bib31","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1073\/pnas.0508235103","article-title":"Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes","volume":"103","author":"Das","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026111311221022800_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/aol-20-38","article-title":"Biology of splenic and nodal marignal zone lymphomas","volume":"5","author":"Spina","year":"2021","journal-title":"Ann Lymphoma"},{"issue":"11","key":"2026111311221022800_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"2026111311221022800_bib34","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.2019002600","article-title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","volume":"134","author":"Hilton","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2026111311221022800_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"2026111311221022800_bib36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"2026111311221022800_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(95)90071-3","article-title":"FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis","volume":"81","author":"Chinnaiyan","year":"1995","journal-title":"Cell"},{"issue":"6","key":"2026111311221022800_bib38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","article-title":"Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases","volume":"27","author":"Camacho","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2026111311221022800_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","article-title":"Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases","volume":"132","author":"Salama","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2026111311221022800_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PAP.0000000000000481","article-title":"Diagnosis and classification of follicular lymphoma and related entities","volume":"32","author":"Laurent","year":"2025","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"2026111311221022800_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","article-title":"Follicular lymphoma and marginal zone lymphoma: how many diseases?","volume":"482","author":"Laurent","year":"2023","journal-title":"Virchows Arch"},{"key":"2026111311221022800_bib42","first-page":"340","volume-title":"The International Consensus Classification of Myeloid and Lymphoid Neoplasms","author":"Sander","year":"2025"},{"issue":"18","key":"2026111311221022800_bib43","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.3390\/cancers15184427","article-title":"Atypical chronic lymphocytic leukemia the current status","volume":"15","author":"Robak","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/22\/7673\/2600129\/blooda_adv-2026-020849-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/22\/7673\/2600129\/blooda_adv-2026-020849-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:22:21Z","timestamp":1794586941000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/22\/7673\/570889\/Nodal-marginal-zone-lymphoma-genetic-analysis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,24]]},"references-count":43,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026,11,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020849","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,24]]},"published":{"date-parts":[[2026,11,24]]}}}